Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...

Half of all pancreatic cancer patients live less than a year after diagnosis. But researchers say there is potential for ...

After two years in the shadows, health stocks are back as a haven for investors navigating economic uncertainty.

Pfizer (PFE) made some major changes to its diversity, equity, and inclusion (DEI) webpage on Thursday, joining other major ...

Pfizer (NYSE:PFE) and GSK (NYSE:GSK) revamp DEI initiatives, emphasizing merit-based diversity amid changing U.S. policies.

Shares of Pfizer Inc. PFE advanced 1.26% to $26.43 Friday, on what proved to be an all-around favorable trading session for ...

For decades, women have trusted Depo-Provera, a birth control injection manufactured by Pfizer, as a convenient and effective ...

Cases in Texas and other states are on the rise, but most of the infected were not vaccinated. Here’s what to know about the ...

Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $30.00. The ...

In a report released today, Geoff Meacham from Citi maintained a Hold rating on Pfizer (PFE – Research Report). The company’s shares closed ...

The molecular glue space has attracted several Big Pharma players over the past few years, including Novo Nordisk, Pfizer and ...

Eisai plans to lay off 121 employees in the U.S. A former deputy director of China's drug agency is under investigation by ...